A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
- Conditions
- Meningitis, CryptococcalHIV Infections
- Registration Number
- NCT00002306
- Lead Sponsor
- Pfizer
- Brief Summary
To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal meningitis in patients who have had an unsatisfactory response to or have experienced unacceptable toxicity with amphotericin B.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (14)
Med College of Georgia
🇺🇸Augusta, Georgia, United States
Washington Univ School of Medicine
🇺🇸St. Louis, Missouri, United States
Univ of South Florida
🇺🇸Tampa, Florida, United States
Univ of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
Univ Hosp
🇺🇸Boston, Massachusetts, United States
Bronx Veterans Administration / Mount Sinai Hosp
🇺🇸Bronx, New York, United States
United States Air Force Med Ctr
🇺🇸Lackland Air Force Base, Texas, United States
Emory Univ School of Medicine
🇺🇸Atlanta, Georgia, United States
Saint Luke's - Roosevelt Hosp Ctr
🇺🇸New York, New York, United States
George Washington Univ Med Ctr
🇺🇸Washington, District of Columbia, United States
Southwest Texas Methodist Hosp
🇺🇸San Antonio, Texas, United States
Univ TX San Antonio Health Science Ctr
🇺🇸San Antonio, Texas, United States
Ann Arbor Veterans Administration Med Ctr
🇺🇸Ann Arbor, Michigan, United States
Cincinnati Veterans Adm Med Ctr / Univ Hosp
🇺🇸Cincinnati, Ohio, United States